Chemotherapy-induced peripheral neuropathy: epidemiology, pathomechanisms and treatment

J Burgess, M Ferdousi, D Gosal, C Boon… - Oncology and …, 2021 - Springer
Purpose This review provides an update on the current clinical, epidemiological and
pathophysiological evidence alongside the diagnostic, prevention and treatment approach …

Pathophysiology of chemotherapy-induced peripheral neuropathy

H Starobova, I Vetter - Frontiers in molecular neuroscience, 2017 - frontiersin.org
Chemotherapy-induced neuropathy is a common, dose-dependent adverse effect of several
antineoplastics. It can lead to detrimental dose reductions and discontinuation of treatment …

Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice …

DL Hershman, C Lacchetti, RH Dworkin… - Journal of clinical …, 2014 - ascopubs.org
Purpose To provide evidence-based guidance on the optimum prevention and treatment
approaches in the management of chemotherapy-induced peripheral neuropathies (CIPN) …

[HTML][HTML] Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention …

B Jordan, A Margulies, F Cardoso, G Cavaletti… - Annals of …, 2020 - Elsevier
Central and especially peripheral neurotoxicities due to systemic antineoplastic therapy are
common and often dose-limiting side-effects. In patients with chemotherapy (ChT)-induced …

Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a randomized clinical trial

EML Smith, H Pang, C Cirrincione, S Fleishman… - Jama, 2013 - jamanetwork.com
Importance There are no known effective treatments for painful chemotherapy-induced
peripheral neuropathy. Objective To determine the effect of duloxetine, 60 mg daily, on …

Recent advances of organogels: from fabrications and functions to applications

L Zeng, X Lin, P Li, FQ Liu, H Guo, WH Li - Progress in organic coatings, 2021 - Elsevier
As a kind of important semi-solid material, the gel has gained increasing attention due to the
high demand for fundamental research and practical applications. Organogels are gels …

Organogels, promising drug delivery systems: An update of state-of-the-art and recent applications

CL Esposito, P Kirilov, VG Roullin - Journal of controlled release, 2018 - Elsevier
Organogels are semi-solid systems with an organic liquid phase immobilized by a three-
dimensional network composed of self-assembled, crosslinked or entangled gelator fibers …

Mechanism-based treatment for chemotherapy-induced peripheral neuropathic pain

M Sisignano, R Baron, K Scholich… - Nature Reviews …, 2014 - nature.com
Chemotherapy-induced peripheral neuropathic pain (CIPNP)—a severe adverse effect
observed in up to 80% of patients during treatment with antineoplastic drugs—limits the …

Chemotherapy-induced peripheral neuropathy (CIPN): current therapies and topical treatment option with high-concentration capsaicin

C Maihöfner, I Diel, H Tesch, T Quandel… - Supportive Care in …, 2021 - Springer
Cancer diagnosis and treatment are drastic events for patients and their families. Besides
psychological aspects of the disease, patients are often affected by severe side effects …

Combination pharmacotherapy for the treatment of neuropathic pain in adults

LE Chaparro, PJ Wiffen, RA Moore… - Cochrane database of …, 2012 - cochranelibrary.com
Background Pharmacotherapy remains an important modality for the treatment of
neuropathic pain. However, as monotherapy current drugs are associated with limited …